Health Care & Life Sciences » Pharmaceuticals | Ilsung Pharmaceutical Co. Ltd.

Ilsung Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
94,836
99,682
70,921
33,760
40,771
53,916
Total Accounts Receivable
22,908
24,925
212,753
215,969
214,366
207,863
Inventories
20,130
17,689
17,857
20,110
23,023
15,386
Other Current Assets
493
543
73
332
650
2,257
Total Current Assets
138,367
142,839
301,604
270,171
278,810
279,422
Net Property, Plant & Equipment
30,078
28,407
28,954
28,514
27,087
25,678
Total Investments and Advances
202,926
206,411
36,097
39,138
40,804
38,354
Intangible Assets
839
714
373
224
218
328
Other Assets
449
-
-
456
542
-
Total Assets
372,659
378,371
367,028
338,502
347,462
347,264
Accounts Payable
5,175
1,842
1,570
1,273
5,286
Income Tax Payable
669
1,673
31,270
1,096
852
Other Current Liabilities
3,812
5,496
6,021
6,748
9,373
Total Current Liabilities
9,656
9,011
38,861
9,117
15,511
Provision for Risks & Charges
2,320
2,248
2,522
2,524
2,214
Deferred Taxes
37,939
38,429
7,303
6,760
6,910
Total Liabilities
49,915
49,688
48,686
18,401
24,635
Common Equity (Total)
322,744
328,683
318,343
320,101
322,826
Total Shareholders' Equity
322,744
328,683
318,343
320,101
322,826
Total Equity
322,744
328,683
318,343
320,101
322,826
Liabilities & Shareholders' Equity
372,659
378,371
367,028
338,502
347,462

About Ilsung Pharmaceutical Co.

View Profile
Address
9 Wonhyo-ro 84-gil
Seoul SL 04315
Korea, Republic Of
Employees -
Website http://www.ilsung-ph.co.kr
Updated 07/08/2019
Ilsung Pharmaceutical Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. Its products include contrast media, patches, antibiotics, antiviral agents, dermatologic agents, cardiovascular agents, antidiabetic agents, analgesics, muscle relaxants, neuropsychiatric agents, antitussives and expectorants. The company was founded by Yoon Byung-Kang in 1954 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.